|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 470.50 USD | +0.79% |
|
+3.72% | +3.68% |
| 06-22 | Proteome contract win; Eco Buildings milestone | AN |
| 06-18 | Vertex Pharmaceuticals Insider Sold Shares Worth $1,827,900, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Other Pharmaceuticals | +0.63% | +3.72% | +3.68% | +5.98% | +150.67% | 118B |  |  | |
- Stock Market
- Stocks
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
